A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Conditions: Plaque Psoriasis Interventions: Drug: Deucravacitinib; Drug: Apremilast Sponsors: Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Modifying PEST for Psoriatic Arthritis Screening
Conditions: Plaque Psoriasis; Psoriatic Arthritis Interventions: Diagnostic Test: PEST Screening group Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Conditions: Plaque Psoriasis Interventions: Drug: ZL-1102; Drug: ZL-1102; Drug: ZL-1102; Drug: Placebo ZL-1102; Drug: Placebo ZL-1102 Sponsors: Zai Lab (Hong Kong), Ltd.; Zai Lab (US) LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
Conditions: Psoriasis Interventions: Drug: Hemay005 Sponsors: Ganzhou Hemay Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Ixekizumab in Patients With Refractory Guttate Psoriasis
Conditions: Guttate Psoriasis Interventions: Biological: Ixekizumab Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Conditions: Psoriasis Interventions: Drug: Hemay005 Sponsors: Ganzhou Hemay Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients
Conditions: Plaque Psoriasis Interventions: Drug: Adalimumab Sponsors: Egymedicalpedia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ethoximod Pharmacokinetics In Healthy Subjects
Conditions: Psoriasis Interventions: Drug: Ethoximod Sponsors: Longevity Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Conditions: Plaque Psoriasis; Psoriasis Interventions: Drug: Cetaphil Sponsors: Galderma R&D Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Understanding Participation Habits Among Plaque Psoriasis Patients
Conditions: Plaque Psoriasis Sponsors: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Bimekizumab in Plaque Psoriasis
Conditions: Plaque Psoriasis Interventions: Drug: Bimekizumab Sponsors: Icahn School of Medicine at Mount Sinai; UCB Pharma; Psoriasis Treatment Center of Central New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
Conditions: Moderate Plaque Psoriasis Interventions: Drug: Risankizumab; Drug: Deucravacitinib Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Combination of Sotyktu and Enstilar for Plaque Psoriasis
Conditions: Psoriasis Interventions: Drug: Enstilar; Drug: Deucravacitinib Sponsors: Psoriasis Treatment Center of Central New Jersey Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Conditions: Generalized Pustular Psoriasis; Erythrodermic Psoriasis Interventions: Drug: TAK-279 Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
